Literature DB >> 9620314

Hepatic steatosis: innocent bystander or guilty party?

C P Day1, O F James.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620314     DOI: 10.1002/hep.510270601

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  91 in total

1.  Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation.

Authors:  Osamah Hussein; Sergio Szvalb; L M Van den Akker-Berman; Nimer Assy
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

Review 2.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 3.  The Activation and Function of Autophagy in Alcoholic Liver Disease.

Authors:  Bilon Khambu; Lin Wang; Hao Zhang; Xiao-Ming Yin
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 4.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

5.  The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease.

Authors:  Filiz Akyüz; Kadir Demir; Sadakat Ozdil; Nevzat Aksoy; Sule Poturoğlu; Duygu Ibrişim; Sabahattin Kaymakoğlu; Fatih Beşişik; Güngör Boztaş; Yilmaz Cakaloğlu; Zeynel Mungan; Uğur Cevikbaş; Atilla Okten
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

6.  Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.

Authors:  David J Orlicky; Andrew E Libby; Elise S Bales; Rachel H McMahan; Jenifer Monks; Francisco G La Rosa; James L McManaman
Journal:  J Physiol       Date:  2019-01-02       Impact factor: 5.182

7.  Comparative studies of early liver dysfunction in senescence-accelerated mouse using mitochondrial proteomics approaches.

Authors:  Yashu Liu; Jintang He; Shaoyi Ji; Qingsong Wang; Hai Pu; Tingting Jiang; Lingyao Meng; Xiuwei Yang; Jianguo Ji
Journal:  Mol Cell Proteomics       Date:  2008-05-29       Impact factor: 5.911

8.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

9.  Long term prognosis of fatty liver: risk of chronic liver disease and death.

Authors:  S Dam-Larsen; M Franzmann; I B Andersen; P Christoffersen; L B Jensen; T I A Sørensen; U Becker; F Bendtsen
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 10.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.